Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-term vs Conventional Glucocorticoids in Adult SSNS
NCT07151456Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Wenzhou Medical University
- Start
- Jan 2026
- Primary completion
- Dec 2029
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial of prednisolone in Idiopathic nephrotic syndrome (INS) (2 arms), sponsored by The First Affiliated Hospital of Wenzhou Medical University. Primary endpoint: Relapse at 2 years. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
prednisolone
03
Conditions
Idiopathic nephrotic syndrome (INS)
Beyond the preview
Go deeper on NCT07151456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07151456.